â– LECTURE OVERVIEW: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer, HNPCC) is an autosomal dominant cancer predisposition syndrome characterized by defective DNA mismatch repair.
â– GENETIC AND BIOCHEMICAL BIOCHEMISTRY:
1. Mismatch Repair (MMR) Defect: Caused by germline mutations in DNA Mismatch Repair genes, primarily MSH2, MLH1, MSH6, and PMS2.
2. Single-Base Mispairings: During S-phase replication, DNA polymerases can accidentally introduce single-base mispairs or small insertion-deletion loops.
3. Splicing Corrections: The MMR system scans newly synthesized strands, excises mispaired bases, and resynthesizes correct sequences.
4. Microsatellite Instability (MSI): Microsatellites are short, repetitive, non-coding DNA sequences prone to polymerase slippage. When MMR is defective, these repeat lengths mutate rapidly, creating a hypermutable state termed Microsatellite Instability (MSI).
5. Two-Hit Hypothesis: Tumorigenesis occurs when the somatic wild-type allele is mutated (second-hit), driving rapid progression of colon adenomas into invasive carcinomas.
â– BIOCHEMICAL MECHANISMS:
At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly.
â– SECONDARY PREVENTION METRICS:
Implementing long-term dietary adaptations, physical therapy, and compliance aids reduces the rate of recurring acute crises by more than half.
[HY-BOARD-1230]
🌟 Dynamic Clinical Key:
Lynch syndrome predisposes patients to proximal (right-sided) colon cancers with a notable lack of heavy pre-existing polyposis. It is also associated with a massive lifetime risk of endometrial cancer in women, as well as ovarian, gastric, small bowel, and transitional cell urothelial tract carcinomas. Focus on rate-limiting regulatory steps for pharmacological design. Patient education regarding warning signs and therapy adherence is the cornerstone of secondary prevention.